Jaguar Health (JAGX) EBITDA Margin (2015 - 2026)
Jaguar Health (JAGX) recorded EBITDA Margin of -581.55% in Q2 2026, down 328.82 percentage points from -252.74% a year earlier and down 634.11 percentage points from the prior quarter.
Powered by 
Analysis
Jaguar Health (JAGX) EBITDA Margin (2015 - 2026) Analysis & Trends
On a TTM basis, Jaguar Health's EBITDA Margin came in at -86.26% as of Jun 30, 2026, up 175.71 percentage points year-over-year; for FY2025, it was -382.20%, down 134.69 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -116.67 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -247.51% in FY2024 (+83.18 pp), -330.68% in FY2023 (-59.41 pp), -271.28% in FY2022 (+628.12 pp) and -899.40% in FY2021 (-633.87 pp).
- Quarterly EBITDA Margin has ranged from -1444.44% in Q3 2021 to 52.56% in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of -26.59 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 2693.40 percentage points in Q2 2022, against a drop of 1266.23 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 52.56% (Q1 2026), -641.89% (Q4 2025) and -219.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Jaguar Health | 963,513.04 | -16.29 Mn | 194,000.00 | -581.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -581.55% |
| Mar 31, 2026 | 52.56% |
| Dec 31, 2025 | -641.89% |
| Sep 30, 2025 | -219.23% |
| Jun 30, 2025 | -252.74% |
| Mar 31, 2025 | -403.88% |
| Dec 31, 2024 | -218.84% |
| Sep 30, 2024 | -218.40% |
| Jun 30, 2024 | -248.07% |
| Mar 31, 2024 | -328.12% |
| Dec 31, 2023 | -306.74% |
| Sep 30, 2023 | -294.45% |
| Jun 30, 2023 | -283.97% |
| Mar 31, 2023 | -473.68% |
| Dec 31, 2022 | -177.52% |
| Sep 30, 2022 | -298.35% |
| Jun 30, 2022 | -202.70% |
| Mar 31, 2022 | -431.54% |
| Dec 31, 2021 | -499.66% |
| Sep 30, 2021 | -1,444.44% |
API Access
Jaguar Health EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=JAGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "JAGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=JAGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();